These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9089625)
1. Binding and distribution of three prototype calcium channel blockers in perfused rat liver. Bikhazi AB; Bitar KM; Kreydiyyeh SI; Saleh RS; el-Kasti MM; Ibrahim MZ; Abu Khoudoud OR Mol Cell Biochem; 1997 Apr; 169(1-2):1-11. PubMed ID: 9089625 [TBL] [Abstract][Full Text] [Related]
2. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit. Striessnig J; Murphy BJ; Catterall WA Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10769-73. PubMed ID: 1660150 [TBL] [Abstract][Full Text] [Related]
3. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines. Reynolds IJ; Snowman AM; Snyder SH J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067 [TBL] [Abstract][Full Text] [Related]
4. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla. Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669 [TBL] [Abstract][Full Text] [Related]
5. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle. Salomone S; Godfraind T Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233 [TBL] [Abstract][Full Text] [Related]
6. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein. Rakotoarisoa L; Sayet I; Mironneau C; Mironneau J J Pharmacol Exp Ther; 1990 Dec; 255(3):942-7. PubMed ID: 2175807 [TBL] [Abstract][Full Text] [Related]
7. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules. Murphy BJ; Tuana BS Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734 [TBL] [Abstract][Full Text] [Related]
8. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes. Miwa K; Miyagi Y; Araie E; Sasayama S Eur J Pharmacol; 1992 Apr; 214(2-3):127-32. PubMed ID: 1325351 [TBL] [Abstract][Full Text] [Related]
10. Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel. Shimasue K; Urushidani T; Hagiwara M; Nagao T Eur J Pharmacol; 1996 Feb; 296(3):347-50. PubMed ID: 8904088 [TBL] [Abstract][Full Text] [Related]
11. Kinetics of lipopolysaccharide clearance by Kupffer and parenchyma cells in perfused rat liver. Bikhazi AB; Jurjus AR; Kamal MT; Al-Housseini AM; Saab RN; Jaroudi WA; Bitar KM Comp Biochem Physiol C Toxicol Pharmacol; 2001 Aug; 129(4):339-48. PubMed ID: 11489431 [TBL] [Abstract][Full Text] [Related]
12. Interactions of spironolactone with (+)-[3H]-isradipine and (-)-[3H]-desmethoxyverapamil binding sites in vascular smooth muscle. Mironneau J; Sayet I; Rakotoarisoa L; Dacquet C; Mironneau C Br J Pharmacol; 1990 Sep; 101(1):6-7. PubMed ID: 2149292 [TBL] [Abstract][Full Text] [Related]
13. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance. Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965 [TBL] [Abstract][Full Text] [Related]
14. The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea-pig ventricular myocytes. Guerra L; Cerbai E; Gessi S; Borea PA; Mugelli A Br J Pharmacol; 1996 Jul; 118(5):1278-84. PubMed ID: 8818354 [TBL] [Abstract][Full Text] [Related]
15. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization. Liu J; Bangalore R; Rutledge A; Triggle DJ Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413 [TBL] [Abstract][Full Text] [Related]
16. Neuropharmacological characterization of voltage-sensitive calcium channels: possible existence of neomycin-sensitive, omega-conotoxin GVIA- and dihydropyridines-resistant calcium channels in the rat brain. Yamada K; Teraoka T; Morita S; Hasegawa T; Nabeshima T Jpn J Pharmacol; 1993 Dec; 63(4):423-32. PubMed ID: 8121077 [TBL] [Abstract][Full Text] [Related]
17. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation. Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of the potent and long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membranes. Miyakoda G; Nakayama N; Matsui K; Yabuuchi Y Arzneimittelforschung; 1995 Apr; 45(4):471-5. PubMed ID: 7779144 [TBL] [Abstract][Full Text] [Related]